The following table summarizes activity in the unrealized gain or loss on available for sale securities included in OCI for the three months ended March 31, 2026 and 2025:


	For the three months ended March 31,
	2026		2025
Balance at beginning of period	$	(31,341,000)	$	(42,671,000)
Unrealized (losses) gains rising during the period	(1,822,000)		5,024,000
Reclassification of net realized gains during the period	(12,000)		—
Related deferred taxes	385,000		(1,055,000)
Net change	(1,449,000)		3,969,000
Balance at end of period	$	(32,790,000)	$	(38,702,000)

The reclassification of realized gains is included in the net securities gains line of the consolidated statements of income and comprehensive income and the tax effect is included in the income tax expense line of the same statement.

The following table summarizes activity in the unrealized loss on securities transferred from available for sale to held to maturity included in OCI for the three months ended March 31, 2026 and 2025:


	For the three months ended March 31,
	2026		2025
Balance at beginning of period	$	(38,000)	$	(47,000)

Amortization of net unrealized gains	4,000		3,000
Related deferred taxes	(1,000)		(1,000)
Net change	3,000		2,000
Balance at end of period	$	(35,000)	$	(45,000)

The following table presents the effect of the Company's derivative financial instruments included in OCI for the three months ended March 31, 2026 and 2025:


	For the three months ended March 31,
	2026		2025
Balance at beginning of period	$	—	$	157,000
Unrealized losses on cash flow hedging derivatives arising during the period	—		(94,000)

Related deferred taxes	—		19,000
Net change	—		(75,000)
Balance at end of period	$	—	$	82,000